BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
GTX, Inc. (NQ: GTXI)
5.800 USD  +0.200 (+3.57%)
Streaming Delayed Price  /  Updated: 10:22 AM EDT, May 21, 2013  /  Add to My Watchlist      
(GTXI) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 21, 2013
(Benzinga, 10/27/10)
Shares of GTx, Inc. (NASDAQ: GTXI) are moving lower on the session; currently the stock is off by 10.97% trading at $2.84. GTXI priced a secondary offering this morning of 14,285,715 shares at $2.80. The gross proceeds to GTx from...(read more)
(Benzinga, 10/4/10)
Shares of GTx, Inc. (NASDAQ: GTXI) are lower on the session by 2.22%, currently trading at $3.52. The stock has been moving largely higher over the past few weeks, moreover since late May, when the stock was trading at $1.90. Options...(read more)
(Stock Wizard, 9/15/10)
Shares of Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) surged as much as 23% after it announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA(TM) (pegloticase), a PEGylated uric acid...(read more)
GTx (GTXI) Company Overview

There is no analysis for GTXI yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here